University of Illinois at Urbana-Champaign Announces Licensing Agreement with Sigma-Aldrich to Provide Membrane Scaffold Proteins for Nanodisc Technology to the Research Community
Sigma-Aldrich Corporation (Nasdaq: SIAL) and the University of Illinois at Urbana-Champaign have entered into a licensing agreement through which Sigma-Aldrich will offer two widely-used membrane scaffold proteins used in Nanodisc technology, developed by Professor Stephen Sligar, Director of the School of Molecular and Cellular Biology.
Did you know? The OTM here at Illinois also acts as the OTM for the University of Illinois at Springfield, and we have been working more closely with them to recognize possible innovations. Senior technology manager, Steve Wille, has been working with Jim Ermatinger, Springfield Dean of LAS, to identify Springfield faculty with the potential to bring their innovations to the market. With 240 faculty members, the Springfield campus has the means for their research to impact their respective fields, and the OTM will guide researchers through the process.
"If you're interested in entrepreneurship and innovative research, you're in the right place," said Larry Schook, Vice President for Research at the University of Illinois at Urbana-Champaign (Illinois), during the Office of Technology Management’s (OTM) Share the Vision 2012 Technology Showcase. Last Thursday and Friday, the OTM hosted its first technology showcase featuring 39 faculty presenters, keynote speakers from federal and state government offices, tours of Research Park, and presentations from Illinois start-ups.
In the near future, electronic textbooks may be the norm for most college students across the country. At the University of Illinois, the wheels are already in motion to make textbooks more affordable through eText, an electronic textbook based on the publishing industry’s standard e-book format, ePub.
New startup out of University of Illinois, Vanquish Oncology, to develop personalized therapeutics for cancer markets
Urbana, IL – Vanquish Oncology, Inc. is a drug development company focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet or underserved cancer markets.
Office of Technology Management Awards Chicoine Scholarship to UI Springfield Student Stephanie Willig
University of Illinois at Springfield Senior Stephanie Willig has been selected as the second David and Marcia K Chicoine Scholar in Science and Technology-Based Economic Development. The term of the scholarship begins in January 2012, and the Scholar works directly for the University’s Office of Technology Management on the Urbana campus.
The University of Illinois and BIOCERES have entered into a licensing agreement regarding the novel gene of amaranthus tuberculatus, or waterhemp plants, in coding resistance to herbicides.
She was given a problem, and she solved it.
Illinois professor Naira Hovakimyan can relate to this statement more than once regarding her career in mathematics and mechanical engineering so far. Recently, the L1 adaptive control solution developed by her and former postdoctoral fellow Chengyu Cao, assistant professor of mechanical engineering at University of Connecticut, has gained attention from numerous organizations who utilize control systems.